4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-267600
Options or other derivatives
- Director acquired 80,286 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2026-06-09 | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | D | ||
| Bronstein Ben Director | 2026-06-09 | Grant or award · Stock Option (Right to Buy) | +5,309 | 5,309 | D | ||
| Bronstein Ben Director | 2026-06-09 | Grant or award · Stock Option (Right to Buy) | +4,977 | 4,977 | D | ||
Loading xslF345X06/ownership.xml…